Misonix has signed a definitive agreement for non-exclusive distribution, with the exception of certain selected accounts, of the BoneScalpel Ultrasonic Bone Cutting System in the US with Aesculap, which replaces a prior exclusive distribution agreement between the parties.
The agreement is limited to clinical applications relative to the spine and cranium.
In response, Misonix will begin the marketing, sales, distribution and service of the BoneScalpel in the US, effective immediately, directly to hospitals and free-standing surgery centers.
In addition to spine and cranial applications, the Misonix sales organization will market the product for a broad range of maxiofacial and other small bone clinical applications.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument while minimizing the peril associated with rotary sharps.